Influenza A virus A/California/7/2009 X-181 (H1N1) antigen (formaldehyde inactivated) Completed Phase 4 Trials for Flu caused by Influenza Prevention

IndicationsStatusPurposePhase
CompletedPrevention4
clinicaltrials.gov IdentifierTitleDrugs
NCT01222403A Post-marketing Study to Monitor the Safety of a MF59-adjuvanted Influenza Vaccine Administered in Korean Subjects Aged 65 Years or Older